Yonsei Med J.  2019 Apr;60(4):401-401. 10.3349/ymj.2019.60.4.401.

The Author Reply: Genetic Data Are a Prerequisite for Interpreting Clinical and Muscle Biopsy Findings in MELAS

• Lee YM

• KMID: 2450198
• DOI: http://doi.org/10.3349/ymj.2019.60.4.401

Abstract

No abstract available.

MeSH Terms

Biopsy*
MELAS Syndrome*

Reference

1. Finsterer J. Clinical perspectives of mitochondrial disorders. Pediatr Endocrinol Rev. 2018; 16:203–208.

2. Lee SJ, Na JH, Han J, Lee YM. Ophthalmoplegia in mitochondrial disease. Yonsei Med J. 2018; 59:1190–1196.

3. Eom S, Lee HN, Lee S, Kang HC, Lee JS, Kim HD, et al. Cause of death in children with mitochondrial diseases. Pediatr Neurol. 2017; 66:82–88.

4. Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012; 1820:619–624.

5. Lee HN, Yoon CS, Lee YM. Correlation of serum biomarkers and magnetic resonance spectroscopy in monitoring disease progression in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes due to mtDNA A3243G mutation. Front Neurol. 2018; 9:621.